Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2012 07:00 ET | Source: Athersys, Inc.

Athersys Receives Cell Therapy Manufacturing Award

CLEVELAND, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced that its subsidiary, ReGenesys BVBA, recently received the BioProcess International Award for the "Technical...
October 26, 2012 15:00 ET | Source: Athersys, Inc.

Athersys to Host Third Quarter 2012 Financial Results Call

CLEVELAND, Oct. 26, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its third quarter 2012 financial results at approximately 4:00 PM (Eastern Time) on Thursday,...
October 26, 2012 09:15 ET | Source: Athersys, Inc.

Athersys Prices Public Offering of Common Stock

CLEVELAND, Oct. 26, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has priced its offering of common stock. The Company has agreed to sell 19,802,000 shares of...
October 15, 2012 11:30 ET | Source: Athersys, Inc.

Athersys Presents New Data Demonstrating Potential Benefits From MultiStem After Spinal Cord Injury

CLEVELAND, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) presented new research results this morning at the Society for Neuroscience annual meeting in New Orleans, demonstrating the...
October 10, 2012 07:00 ET | Source: Athersys, Inc.

Publication Indicates That MultiStem Treatment May Reduce Inflammation and Promote Reparative Processes Following Acute Brain Injury

CLEVELAND, Oct. 10, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today the publication of an article in the peer-reviewed scientific journal, Journal of Neuroinflammation, that...
October 05, 2012 07:00 ET | Source: Athersys, Inc.

Athersys Presents Research Progress in Its Multiple Sclerosis Program

CLEVELAND, Oct. 5, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today it is presenting new research results at the Second Midwest Conference on Stem Cell Biology & Therapy at...
October 02, 2012 07:00 ET | Source: Athersys, Inc.

Athersys Reports on Progress in Phase 2 Study of MultiStem for Ischemic Stroke

CLEVELAND, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) recently completed enrollment of the first patient cohorts of its Phase 2 study of MultiStem®, a novel adult stem cell...
September 18, 2012 09:00 ET | Source: Athersys, Inc.

Athersys CEO to Present on September 24, 2012 at the Noble Financial Life Sciences Exposition

CLEVELAND, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys, Inc. (Nasdaq:ATHX) will present at the Noble Financial Capital Markets Life Sciences...
August 13, 2012 16:05 ET | Source: Athersys, Inc.

Athersys Reports Second Quarter 2012 Results

CLEVELAND, Aug. 13, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the second quarter ended June 30, 2012. Second quarter and recent highlights...
July 18, 2012 16:00 ET | Source: Athersys, Inc.

Athersys to Host Second Quarter 2012 Financial Results Call

CLEVELAND, July 18, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its second quarter 2012 financial results at approximately 4:00 PM (Eastern Time) on Monday,...